The results indicated that RENT3B expression was significantly associated with eight types of cancers: blood tumor, brain cancer, breast cancer, colorectal cancer, lung cancer, ovarian cancer, skin cancer, and soft tissue tumor (Fig. 2). This evidence concerns the gene UPF3B and breast carcinoma.